This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
ADC Therapeutics SA
Q22025
8/12/2025
Operator
Conference Operator
Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics FA-ADCT Q2 2025 Earnings Conference Call. At this time, all lines are in the listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Tuesday, August 12, 2025. I will now turn the call over to Nicole Riley, Head of Investor Relations and Corporate Communications for ADC Therapeutics.
Operator
Conference Operator
Nicole, please go ahead.
Nicole Riley
Head of Investor Relations and Corporate Communications
Thank you, operator.
You're reading a preview of the ADCT Q2 2025 earnings call.
Free account.
Disclaimer